MDAnywhere

Preparation / pathway

Online physician assessment with prescriptions sent to a pharmacy

Published price

Three-month treatment consultation $69; one-month figures conflict

Conditions to confirm

The ED page shows $39 near the top and $36 on a lower one-month button. Medicine is excluded; no subscription fee is advertised. Confirm eligibility and the final quote.

The assessment is described as asynchronous

MDAnywhere's ED page describes an online questionnaire and physician review without a voice or video call. It lists sildenafil, tadalafil and vardenafil among generic options and says prescriptions are sent to the patient's pharmacy. Its general service page identifies medical evaluations as provided by Access Medical Associates, PLLC. [ED page] [Service overview]

The ED page presents ages 25–69 near the top and broader “25+” wording later. Confirm actual eligibility and state availability rather than treating either snippet as the whole rule. It also directs new ED concerns to in-person evaluation. That is the service's published scope, not a diagnostic conclusion about an individual reader.

The one-month price is inconsistent

The reviewed page shows $39 for a one-month treatment consultation in its opening offer and $36 on a lower button. The three-month consultation is consistently displayed at $69. We keep the one-month discrepancy visible and recommend obtaining the current selected quote.

Medication is explicitly excluded and paid at the pharmacy; the service advertises no subscription fee. A general consultation-from-$29 statement elsewhere on the page should not replace the ED-specific amounts. We have not completed checkout or tested billing and refunds.

The follow-up window is part of the arrangement

The ED page describes portal messaging for up to one week after a visit and says additional health concerns require another visit. It also says there is no charge when online treatment is not recommended. Confirm how those statements apply to the request and any payment authorization before relying on them.

NIDDK's assessment information and medication guidance can help prepare questions beyond the commercial offer. Read the product-identity guide and the pharmacy guide. This profile does not independently verify provider credentials, response-time promises or clinical outcomes. [Assessment] [Sildenafil] [Pharmacy checks]